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Abstract: The G protein coupled receptors (GPCR) represent the target class for nearly half of the current therapeutic 
drugs and remain to be the focus of drug discovery efforts. The complexity of receptor signaling continues to evolve. It is 
now known that many GPCRs are coupled to multiple G-proteins, which lead to regulation of respective signaling path-
ways downstream. Deciphering this receptor coupling will aid our understanding of the GPCR function and ultimately de-
veloping drug candidates. Here, we report the development of four homogenous bioluminescent reporter assays using im-
proved destabilized luciferases and various response elements: CRE, NFAT-RE, SRE, and SRF-RE. These assays allowed 
measurement of major GPCR pathways including cAMP production, intracellular Ca
2+ mobilizations, ERK/MAPK activ-
ity, and small G protein RhoA activity, respectively using the same reporter assay format. We showed that we can deci-
pher G protein activation profiles for exogenous m3 muscarinic receptor and endogenous 2-adrenergic receptors in 
HEK293 cells by using these four reporter assays. Furthermore, we demonstrated that these assays can be readily used for 
potency rankings of agonists and antagonists, and for high throughput screening. 
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INTRODUCTION 
  G protein coupled receptors (GPCRs, or 7TM receptors), 
constitute the largest superfamily of cell surface receptors 
and play key roles in regulation of wide variety of physio-
logical processes, including cognition, metabolism, inflam-
mation, immunity and cell proliferation and development 
[1]. As a result, GPCRs have been popular drug targets, and 
nearly half of approved drugs on the market directly target 
GPCRs. Despite the large number of GPCRs that are avail-
able as potential drug targets, currently approved drugs only 
address a small portion of receptors while hundreds are un-
der development. Thus, this target class remains of strong 
interest for drug discovery.  
  GPCRs transmit extracellular signals across the plasma 
membrane  via  intracellular coupling with heterotrimeric G 
proteins. Heterotrimeric G proteins are classified into four 
subfamilies based on their G subunit, Gs, Gi, Gq and G12. 
Upon activation of GPCRs, G protein  subunit dissociates 
from  dimeric subunit, which in turn initiates a cascade of 
downstream second messenger pathways and eventually in-
duces gene transcription by various response elements in-
cluding cAMP response element (CRE), nuclear factor of 
activated T-cells response element (NFAT-RE), serum re-
sponse element (SRE) and serum response factor response 
element (SRF-RE, a mutant form of SRE) (Fig. 1). Over the 
past few decades there have been many substantial discover-
ies regarding GPCRs structure and function including -
arrestin-dependent signaling, allosteric modulation, func-
tional selectivity and receptor dimerization that have led to 
the current understanding of the complexity of receptor sig-
naling [2-4]. Some GPCRs only couple to one type of G pro-
tein (e.g., Gs), but many GPCRs are known to couple to a 
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broad range of G-protein families, such as Gi/G12, Gq/G12, or 
Gi/Gq/G12 in a cell type-dependent or compound-specific 
manner [5]. Current methods employed in GPCR screening 
programs measure G protein signaling by determining 
change in second messengers such as cAMP, inositol 
trisphosphate (IP3), and intracellular Ca
2+ mobilizations, 
which often demands setting up different assay platforms 
and requires specialized instrumentation for each pathway 
which could be costly [6]. Plus, HTS-compatible methods 
for G12-RhoA detection is lacking. Thus, despite of the de-
mands of screening assays for multiple functional readouts, 
the practical execution for drug screening has been slow.  
  Reporter gene system is a technology where a reporter 
gene is synthesized in response to activation of a specific 
signaling cascade of interests, followed by monitoring of the 
reporter protein expression by its enzymatic activities linked 
with a variety of colormetric, fluorescent or luminescent 
read-outs. Due to its inherent sensitivity, large signal dynam-
ics and simplicity to set up, reporter assay platform has been 
widely used as high throughput homogenous assay for 
screening GPCR targets linked to cAMP or Ca
2+ signaling 
[7]. Despite the success, some concerns were raised. These 
include the requirement of a long induction time, false posi-
tives and the fact that signal event is distal from receptor 
activation. These concerns have been addressed in a number 
of approaches such as the use of destabilized reporters and 
co-expression of a constitutively expressed internal control 
[7, 8]. The high number of false positives due to the fact that 
the signaling event measured is so distal from receptor acti-
vation could be minimized by coexpression of a constitu-
tively expressed internal control reporter [8]. Here, we report 
the development of a series of homogenous bioluminescent 
reporter assays using reporter vectors with CRE-, NFAT-RE-
, SRE-, SRF-RE- built in upstream of destabilized luciferase 
gene to measure four major GPCR signaling events: change 
in cAMP level, Ca
2+ mobilization, ERK/MAPK activity and GPCR Luciferase Reporter Assays  Current Chemical Genomics, 2010, Volume 4    85 
small G protein RhoA activation. By using various reporter 
vectors together, we can measure receptor/G protein cou-
pling profiles for individual receptors, and further compare 
the potency rankings of various compounds for the same 
receptor to activate multiple signal pathways. Thus, lu-
ciferase reporter assay provides an efficient approach to de-
cipher major GPCR pathways in one simple assay format, 
which can be used to develop robust HTS assays for drug 
discovery.  
MATERIALS AND METHODOLOGY 
Materials  
 pGL4.26[luc2/Hygro], pGL4.27[luc2P/Hygro], pGL4.28 
[luc2CP/Hygro], pGL4.29[CRE/minP/luc2P], pGL4.30 
[NFAT-RE/ minP/luc2P], and pF9A CMV hRluc-neo Flexi 
vectors, and PMA were from Promega (Madison, WI). All 
other reagents were from Sigma (St. Louis, MO). 
Plasmid Construction 
  The DNA sequences of five copies of the SRE or SRF-
RE were synthesized by Integrated DNA Technologies, Inc. 
(Coralville, Iowa). SRE- and SRF-RE- reporter were con-
structed by insertion of SRE or SRF-RE into pGL4.26, 
pGL4.27, or pGL4.28 using Hind III and Bgl II restriction 
enzyme sites. The resulting constructs from pGL4.27 were 
named as pGL4.33 [SRE/luc2P] and pGL4.34[SRF-
RE/luc2P], respectively.  
  The human dopamine D1 receptor (accession number 
NM_000794) was obtained from American Type Culture 
Collection (Manassas, VA). The m3 muscarinic receptor 
(NM_000740.2) was acquired from Origene (Rockville, 
MD). The coding sequences of both receptors were sub-
cloned into pF9A CMV hRluc-neo Flexi Vector to make 
receptor-Renilla fusion proteins. The constructs for m4 mus-
carinic receptor were from UMR cDNA Resource Center 
(Rolla, MO). All sequences were verified by restriction di-
gest and sequencing.  
Cell Culture, Transfection and Generation of Stable 
HEK293 Cell Lines 
  HEK293 cells were cultured in DMEM (Life Technolo-
gies) supplemented with 10% fetal bovine serum at 37
oC 
with a humidified atmosphere at 5% CO2. Transient tranfec-
tions were done using TransIT®-LT1 Transfection Reagent 
following manufacturer’s protocol (Mirus Bio). Cells were 
directly plated and transfected in 96-well plate, or plated and 
transfected in T75 flask, then plated into 384-well plate 4-6 
hours after transfection. The cells were changed to serum-
starving medium 4-6 hours after transfection and assayed 20 
hours later for SRE- or SRF-RE- reporter assay, or assayed 
24 hours after transfection for CRE- or NFAT-RE- reporter 
assay.  
  Stable HEK293 cell lines expressing reporter vectors 
(CRE-, NFAT-RE, SRE-, SRF-RE-) were generated by tran-
sient transfection followed by hygromycin selection and lim-
iting dilution cloning. Double stable cell lines co-expressing 
reporter vector and receptor (D1 dopamine receptor and m3 
muscarinic receptor) were generated by transfection of re-
ceptor construct into single stable line expressing corre-
sponding reporter vector. Cells were plated in complete me-
dium for CRE- or NFAT-RE- assay, or plated in DMEM 
plus 2% charcoal/dextran treated FBS (Thermo Scientific) 
for SRE- or SRF-RE- assay 24 hours before assay.  
Luciferase Reporter Assays 
 Firefly  and  renilla luciferase activities, as indicated by 
relative luminescence units (RLU) were determined using 
One-Glo or Dual-Glo luciferase assay kits (Promega) accord-
















Fig. (1). Schematic diagram showing major GPCR signaling pathways. Upon stimulation, Gs coupled receptors activate adenylyl cyclase 
(AC) resulting in an increase of cAMP; Gi-coupled receptors inhibit AC, and the  subunits activate ERK pathway; Gq coupled receptors 
activate phospholipase C (PLC) to produce inositol trisphosphate (IP3) and diacylglycerol (DAG), which in turn increases intracellular cal-
cium concentration (Ca
2+); G12-coupled receptors activate small G protein RhoA GTPase.  86    Current Chemical Genomics, 2010, Volume 4  Cheng et al. 
induction = firefly RLUinduced / firefly RLUuninduced. For an-
tagonist, % of control=100  firefly RLU(agonist+antagonist) / fire-
fly RLUagonist alone, all normalized to renilla RLU. Both EC50 
and IC50 values were generated using GraphPad Prism soft-
ware. Z’ values were determined as Z’=1- [(3SDinudced + 
3SDuninduced) / (averageinduced – averageuninduced)].  
RESULTS AND DISCUSSION 
Improved Assay Performance by Using Destabilized Lu-
ciferase Reporter  
  Previously, we have shown that the luciferase reporter 
vectors (pGL4 series) containing minimal promoter and de-
stabilized
  luciferase gene improve the responsiveness of 
cAMP response element to Gs coupled receptor [8]. To 
evaluate if this is also applicable for other response elements 
which are specific for different signal pathways, we con-
structed SRE- and SRF-RE- reporter in various pGL4 vec-
tors containing luciferase gene with or without protein deg-
radation sequence hPEST (Pro-Glu-Ser-Thr) and CL1 [9, 10] 
as shown in Fig. (2A). SRE is known to respond to ternary 
complex factor (TCF)-dependent ERK/MAPK pathway, 
while SRF-RE, a mutant form of SRE lacking TCF binding 
domain, is newly designed to respond to SRF-dependent and 
TCF-independent pathway such as RhoA activation [11]. 
GPCRs, particularly those coupled with Gi and Gq activate 





























Fig. (2). Destabilized luciferase genes increase the reporter response and reduce the assay time to reach maximum induction. luc2, firefly 
luciferase; luc2P, firefly luciferase with hPEST sequence; luc2CP, firefly luciferase with hCL1 and hPEST sequences. HEK293 cells tran-
siently expressing various versions of SRE- or SRF-RE- reporters (luc2, luc2P or luc2CP) were serum starved, induced with 20% FBS plus 
10ng/ml PMA for SRE (2B, 2D), or with 20% FBS for SRF-RE (2C, 2E) for 2-8 hours. Cells not induced after serum starvation were used as 
control (uninduced). Firefly luciferase activity (RLU) were determined using One-Glo assay system and measured on the GloMax 96 multi-
plate luminometer. (2B, 2C) Firefly luciferase activity (RLU) and fold of induction measured after six hours of induction. (2D, 2E) Time 
course of fold of induction of SRE- and SRF-RE measured every two hours for 8 hours after induction.  GPCR Luciferase Reporter Assays  Current Chemical Genomics, 2010, Volume 4    87 
of SRE, while GPCRs coupled with G12 family are known to 
activate Rho guanine nucleotide exchange factors (Rho-
GEFs) which leads to activation of RhoA and transcriptional 
activation of SRF-RE [12]. This is particularly important 
with increasing interests in HTS drug screening targeting 
G12/RhoA pathway while there are no HTS-compatible 
methods available for G12/RhoA so far.  
  SRE-mediated gene transcription is known to be rapidly 
induced by serum, phorbol esters and growth factors in TCF 
and SRF-dependent manner, while SRF alone can mediate 
transcription activation of SRF-RE by serum mostly through 
the binding to cell surface receptors of the mitogenic agents 
such as LPA in serum [11, 12]. Thus, to establish our assay 
we first used serum plus PMA to stimulate SRE reporter, and 
used serum alone to simulate SRF-RE reporter. When vari-
ous SRE- or SRF-RE reporters were transiently transfected 
into HEK293 cells, the luciferase reporters containing pro-
tein degradation sequence hPEST (luc2P), or both hPEST 
and CL1 (luc2CP) showed 5-10 times lower assay back-
ground due to decreased basal expression level of reporter 
proteins (Fig. 2B, 2C). The cells were further induced with 
FBS plus PMA (for SRE-) or FBS alone (for SRF-RE-) for 
different time points up to 24 hours (data not shown for 8+ 
hour time point). As shown in Fig. (2D and 2E), the destabi-
lized SRE- and SRF-RE- reporters reached the maximum of 
response in a shorter time (2-6 hours) than traditional lu-
ciferase gene (8+ hours).  
  The long incubation time required by traditional reporter 
assays has limited the application of reporter technology in 
HTS drug screening due to the concerns of cytotoxicity by 
the compounds. Therefore, deployment of the destabilized 
reporter gene will remove this hurdle with improved re-
sponse dynamics and reduced assay time (2-6 hours) which 
in turn could potentially minimize secondary effects (such as 
toxicity effect) arising from the prolonged incubation of cells 
with chemical compounds. Here we have shown that Luc2P 
versions of SRE and SRF-RE reached the peak response in 
six hours (Fig. 2D, 2E) with minimal sacrifice of basal re-
porter expression (Fig. 2B,  2C). Similar results were ob-
served when we further measured several GPCR responses 
by comparing these SRE- or SRF-RE reporters with or with-
out protein degradation sequences (data not shown), con-
firming the potentials of using destabilized luciferase report-
ers in GPCR drug screening. Thus, in consideration of both 
assay dynamics and signal output, we chose the reporter vec-























Fig. (3). GPCR assays for Gs, Gi, Gq, and G12 coupled receptors in 384-well format. HEK293 cells used are either stably expressing D1 do-
pamine receptor and CRE-luc2P (A), m3 muscarinic receptor with NFAT-RE-luc2P reporter (B), SRF-RE-luc2P reporter (test endogenous 
EDG receptor) (D), or transiently expressing m4 muscarinic receptor with SRE-luc2CP reporter (C). Cells were induced with various ago-
nists in 384-well format. Agonists used (time of induction): 1 μM dopamine (4 hours); 1 μM muscarine chloride (8 hours); 10 μM acetylcho-
line (2 hours); 10 μM LPA (6 hours); Firefly luciferase activity was measured using One-Glo assay system. Fold of induction and Z’ values 
were determined as described in “Materials and Methodology”.  88    Current Chemical Genomics, 2010, Volume 4  Cheng et al. 
with luciferase, SRE-luc2P and SRF-RE-luc2P and six hour 
induction time for most of the following evaluation, unless 
otherwise indicated.  
Amenable for High Throughput Screening 
  To determine if luciferase reporter assay is amenable for 
high-throughput screening for GPCR modulators linked with 
all major G protein signaling, we chose four individual re-
ceptors including D1 dopamine receptor, m4 muscarinic re-
ceptor, m3 muscarinic receptor and endogenous EDG recep-
tor, which are known to couple with Gs, Gi, Gq and G12 sub-
family respectively, and co-expressed them with the corre-
sponding reporters. In the cases of Gs, Gq and G12 signaling, 
luc2P version of reporters (CRE-luc2P, NFAT-RE-luc2P, 
SRF-RE-luc2P) were tested and shown to give maximal as-
say performance, while luc2CP of SRE reporter was used for 
detection of Gi-linked MAP kinase activation in order to 
achieve optimized assay dynamics (Fig. 3, Table 1).  
  Cells expressing luciferase reporter and receptors were 
induced in a 384-well plate with various agonists for two to 
eight hours depending on the requirement of the response 
elements, RLUs were measured and Z’-factor values were 
then determined. Z’-factor is one of the major statistical pa-
rameters commonly used to evaluate assay performance in 
high throughput screening. According to the formula, the 
closer the Z’-factor is to 1, the better the assay quality is. In 
Table 1.  Summary of Fold Change and Z’ Value of Four Different Receptors Known to Couple with Different G Protein Path-









CRE-luc2P DRD1 G s 366 0.78 
NFAT-RE-luc2P M 3R Gq 49 0.79 
SRE-luc2CP M 4R Gi 11 0.85 






















Fig. (4). Profiling of receptor/G protein coupling. HEK293 cells transiently expressing various luciferase reporters as indicated: CRE-luc2P 
(A), NFAT-RE-luc2P (B), SRE-luc2P (C) or SRF-RE-luc2P (D) were induced with carbachol (for exogenously introduced m3 muscarinic 
receptor) or isoproterenol (for endogenous 2-adrenergic receptor) for six hours in 96-well format. Firefly luciferase activity was measured 
using One-Glo assay system.  GPCR Luciferase Reporter Assays  Current Chemical Genomics, 2010, Volume 4    89 
general, Z’ values greater than 0.5 are acceptable for HTS 
[13]. As shown in Table 1, all four reporter assays showed 
Z’-factor values significantly higher than 0.5 in 384-well 
format with large response dynamic (fold of induction) range 
from 10 to 300 fold. Thus, luciferase reporter assays are ro-
bust, and can be used for high throughput screening of 
modulators for all major G protein pathways.  
Deciphering GPCR Coupled Signaling Pathways  
  We next evaluate if luciferase reporter assay can be used 
to profile receptor/G protein coupling in HEK293 cells. It is 
known that the m3 muscarinic receptor, when exogenously 
expressed, couples with both Gq and G12 pathways, while 
endogenously expressed 2-adrenergic receptors mostly acti-
vate Gs protein. When we overexpressed m3 muscarinic re-
ceptor in cells in four individual reporter assays, receptor 
activation by agonist carbachol induced dose-dependent ex-
pression of luciferase with distinguishable potencies (Fig. 4). 
As indicated in Table 2, NFAT-RE-, SRE- and SRF-RE as-
says showed similar EC50 values by carbachol stimulation, 
suggesting that activation of m3 muscarinic receptors leads to 
increase of intracellular calcium concentration, MAP kinase 
and RhoA activation with similar efficacies. In contrast, 
EC50 values shown by CRE- reporter assay was almost three 
logs higher than those by other reporter assays tested, indi-
cating that m3 muscarinic receptors activate cAMP produc-
tion in a much less efficient manner. In contrast, activation 
of  2-adrenergic receptors by isoproterenol showed dose-
dependent response in CRE-reporter assay, but not in NFAT-
RE-, SRE- and SRF-RE- reporter assays, confirming that the 
major downstream signaling for 2-adrenergic receptors is 
cAMP pathway via  Gs protein. Thus, luciferase reporter 
technology is able to study G protein activation profiles by 
the same receptor in one single assay format.  
  Many GPCRs activate a variety of signaling pathways 
via distinct G proteins in cell type dependent manner, which 
is crucial for their precise regulation of tissue-specific 
physiological functions [14]. Unfortunately many of the cur-
rent available screening methods have limitations and are 
Table 2.  Comparison of EC50 of Agonist-Induced Activation 
of m3 Muscarinic Receptor or of Endogenous 2-
Adrenergic Receptor Measured by Four Luciferase 
Reporter Assays 
RE M3R (M)  2AR (M) 
CRE >  1.6   10
-4 9.2  10
-8 
NFAT-RE 8.0   10
-8 N/A 
SRE 1.2   10
-7 N/A 






















Fig. (5). Potency ranking of agonists and antagonists for m3 muscarinic receptor using NFAT-RE- and SRE- reporters. HEK293 cells were 
transiently transfected with NFAT-RE-luc2P (A, B) or SRE-luc2P (C, D) along with m3 muscarinic receptor (M3R)-Renilla fusion for 
twenty-four hours. Firefly luciferase activity was measured after 6 hours induction with addition of 1:3 serial dilutions of various agonists 
(A, C) or antagonists in the presence of 100 nM muscarine chloride (B, D) using the Dual-Glo assay system in 96-well format. Fold of induc-
tion and % of control were determined as described in “Materials and Methodology”.  90    Current Chemical Genomics, 2010, Volume 4  Cheng et al. 
unable to measure multiple GPCR signaling events in one 
assay format. Also, not all GPCR signaling such as RhoA 
activity can be measured in HTS format. Thus, despite sig-
nificant interest in profiling for cell type dependent recep-
tor/G protein coupling, it has been progressed rather slowly 
in current drug discovery practice, partly due to the burden 
setting up multiple assay platforms and lack of existing de-
tection tools. The bioluminescent reporter assay using desta-
bilized luciferase is fast, highly sensitive and easy to set up. 
More importantly, as we have shown here in Fig. (4), biolu-
minescent reporter assays can measure all major GPCR sig-
naling via Gs, Gi, Gq and G12 pathways in one single assay 
format with great assay dynamics and Z’ values, thereby 
they could be potentially used to monitor cell type-dependent 
signaling via G protein coupled receptors.  
Potency Ranking of GPCR Modulators for Different G 
Protein Pathways  
  Since NFAT-RE- or SRE-luc2P reporters respond nicely 
to activation of m3 muscarinic receptor (Fig. 4 ), we next 
compared the potency ranking of a series of well-known 
compounds for m3 muscarinic receptor using both reporter 
assays. As expected, co-transfection of either reporter vector 
with m3 muscarinic receptor showed a large dynamic range 
of assay response upon agonist stimulation and both reporter 
assays showed identical orders of potency ranking for the 
agonists and antagonists we tested (Fig. 5). The order of po-
tency rankings for agonists were: muscarine chlo-
ride>carbachol>pilocarpine; The IC50s for antagonists were 
ranked as: scopolamine>pirenzipine, in the presence of mus-
carine chloride. Both potency rankings are consistent with 
those reported in the literature (Table 3). The potencies of 
same compound/receptor pairs attained from two reporter 
assays are all within a half-log range, suggesting none of the 
compounds showed functional selectivity (Fig. 5).  
Table  3.  Comparison of EC50 (Agonists) and IC50 (Antago-
nists) for m3 Muscarinic Receptor by NFAT-RE- 
and SRE- Luciferase Reporter Assays 
agonist NFAT-RE,  EC50 (M) SRE,  EC50 (M) 
muscarine chloride  8.3  10
-9 2.8  10
-8 
carbachol 3.6   10
-8 1.1   10
-7 
pilocarpine 2.0   10
-7 5.2   10
-7 
 
antagonist NFAT-RE,  IC50
 
(M) SRE,  IC50
 
(M) 
pirenzipine 9.0   10
-7 2.2  10
-7 
scopolamine 1.8   10
-9 7.1   10
-10 
 
  More evidence indicates that same receptor could acti-
vate various signaling pathways with distinct potencies de-
pending on the modulators which could bind to the receptor 
orthosterically or allosterically. This new concept offers 
great potential for developing pathway-specific drugs that 
increase efficacy and reduce side effects, but at the same 
time add another dimension in assay complexity to drug dis-
covery. In the case of m3 muscarinic receptor, activation of 
m3 muscarinic receptor increases intracellular Ca
2+ mobiliza-
tion and induces ERK/MAPK pathway at the same time, 
however, it is also reported that MAPK activity via m3 mus-
carinic receptor is regulated in a calcium-dependent or inde-
pendent manner in a variety cell types, suggesting the in-
volvement of distinct signal mechanisms [15]. Therefore, by 
comparing the potencies of same compound/receptor pairs 
using multiple reporter vectors which measure different G 
protein downstream signaling, this approach has great poten-
tial in drug screening for GPCR modulators with functional 
selectivity in one simple assay format.  
CONCLUSION 
  In this study, we developed four homogenous biolumi-
nescent reporter assays using destabilized luciferase. The 
improved reporter assays showed larger assay dynamics in 
shorter assay time than using regular luciferase. Using a 
model system of exogenous or endogenous receptors in 
HEK293 cells, we demonstrated that all four major G protein 
subfamilies and downstream pathways can be studied in one 
luciferase reporter assay format. Furthermore, these assays 
can be readily used for potency rankings of GPCR modula-
tors and for high throughput screening. Together, our data 
suggest that these improved luciferase reporter assays are 
well suited for GPCR research and drug screening, with po-
tential application in establishing receptor/G protein profiles 
for any particular receptor and drug screening for pathway-
specific GPCR modulators. 
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